BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24465811)

  • 21. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
    Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
    Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, Indonesia.
    Wildeman MA; Fles R; Adham M; Mayangsari ID; Luirink I; Sandberg M; Vincent AD; Fardizza F; Musa Z; Armiyanto ; Middeldorp JM; Gerritsen G; Suwanto R; Tan IB
    PLoS One; 2012; 7(3):e32756. PubMed ID: 22431981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO).
    Tonoli S; Alterio D; Caspiani O; Bacigalupo A; Bunkheila F; Cianciulli M; Merlotti A; Podhradska A; Rampino M; Cante D; Bruschieri L; Gatta R; Magrini SM
    Strahlenther Onkol; 2016 Dec; 192(12):931-943. PubMed ID: 27761611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing radiotherapy with or without intracavitary hyperthermia in the treatment of primary nasopharyngeal carcinoma: a retrospective analysis.
    Wen QL; He LJ; Ren PR; Chen CQ; Wu JB
    Tumori; 2014; 100(1):49-54. PubMed ID: 24675491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
    Yao JJ; Jin YN; Wang SY; Zhang F; Zhou GQ; Zhang WJ; Zhi-Bin ; Cheng ; Ma J; Qi ZY; Sun Y
    BMC Cancer; 2018 Jul; 18(1):740. PubMed ID: 30012115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
    Lee VH; Kwong DL; Leung TW; Ng SC; Lam KO; Tong CC; Sze CK
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1067-1078. PubMed ID: 27738820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.
    Fles R; Bos ACRK; Supriyati ; Rachmawati D; Waliyanti E; Tan IB; Haryana SM; Schmidt MK; Dewi FST
    BMC Public Health; 2017 May; 17(1):510. PubMed ID: 28545416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of magnetic resonance imaging in determining treatment response and local recurrence in nasopharyngeal carcinoma treated curatively.
    Meng K; Tey J; Ho FCH; Asim H; Cheo T
    BMC Cancer; 2020 Mar; 20(1):193. PubMed ID: 32143592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.
    Kwong DL; Sham JS; Chua DT; Choy DT; Au GK; Wu PM
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):703-10. PubMed ID: 9336153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).
    Jagdis A; Laskin J; Hao D; Hay J; Wu J; Ho C
    Am J Clin Oncol; 2014 Feb; 37(1):63-9. PubMed ID: 23111356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
    Wu MY; He XY; Hu CS
    PLoS One; 2016; 11(4):e0154501. PubMed ID: 27119991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma.
    Tuan JK; Ha TC; Ong WS; Siow TR; Tham IW; Yap SP; Tan TW; Chua ET; Fong KW; Wee JT
    Radiother Oncol; 2012 Sep; 104(3):305-11. PubMed ID: 22280806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.
    Lee AW; Kwong DL; Leung SF; Tung SY; Sze WM; Sham JS; Teo PM; Leung TW; Wu PM; Chappell R; Peters LJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):75-85. PubMed ID: 12007944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
    Chow JCH; Tam AHP; Cheung KM; Lee VHF; Chiang CL; Tong M; Wong ECY; Cheung AKW; Chan SPC; Lai JWY; Ngan RKC; Ng WT; Lee AWM; Au KH
    Oral Oncol; 2020 Dec; 111():105012. PubMed ID: 32980659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
    Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
    Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
    Peng G; Wang T; Yang KY; Zhang S; Zhang T; Li Q; Han J; Wu G
    Radiother Oncol; 2012 Sep; 104(3):286-93. PubMed ID: 22995588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.